Paul Ehrlich Institute / Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel (PEI)

Research facility


Location: Langen, Germany (DE) DE

ISNI: 0000000110190926

ROR: https://ror.org/00yssnc44

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Pooled analyses of Clostridioides difficile vaccine trials identify baseline predictors for vaccine response (2026) Stojkov I, Marchioro L, Bekeredjian-Ding I, Hofner B Journal article The use of complex clinical trials: a regulatory review (2026) Nguyen Q, Kästel H, Hees K, Hofner B Journal article, Review article Insights into Api m 10-Isoforms and Splice Variants: More Than One Major IgE-Binding Epitope (2026) Paulus-Tremel KE, Wolff MB, Novak N, Wagner N, Landgraf A, Schülke S, Holzhauser T, Mahler V Journal article European Society of Contact Dermatitis Guideline for Diagnostic Patch Testing—Recommendations on Best Practice (Update 2026) (2026) Uter W, Aerts O, Agner T, Brans R, Bruze M, Cannavó A, Crépy MN, et al. Journal article Clinical trials with interim analyses: standardizing terminology to increase clarity (2025) Asikanius E, Hofner B, Hampson LV, Wassmer G, Jennison C, Mielke T, Kunz CU, Rufibach K Journal article Enhanced invasion and survival of antibiotic- resistant Klebsiella pneumoniae pathotypes in host cells and strain-specific replication in blood. (2025) Klaper K, Pfeifer Y, Heinrich L, Prax M, Krut O, Bekeredjian-Ding I, Wahl A, et al. Journal article Variability in Paediatric Patch Test Practices Across Europe: A Survey From the European Baseline Series (EBS) Working Party on Behalf of the European Society of Contact Dermatitis (ESCD) (2025) Aerts O, Rustemeyer T, Belloni-Fortina A, Badulici S, Dickel H, Garcia Abujeta JL, Giménez-Arnau AM, et al. Journal article T-bet+ B cells are activated by and control endogenous retroviruses through TLR-dependent mechanisms (2024) Rauch E, Amendt T, Lopez Krol A, Lang FB, Linse V, Hohmann M, Keim AC, et al. Journal article Marketing authorisation for rare diseases: The European regulatory perspective using the example of gene and cell therapies Arzneimittelzulassung im Bereich seltener Erkrankungen: die europäische regulatorische Perspektive am Beispiel der Gen- und Zelltherapeutika (2024) Schüßler-Lenz M, Hofner B Journal article Möglichkeiten der Fertigung von Testallergenen in öffentlichen Apotheken zur Diagnostik von Typ I-Allergien – rechtliche Aspekte (2024) Jost R, Kespohl S, Paulus-Tremel KE, Zimmer J, Bonertz A, Sander I, Klose T, et al. Journal article, Review article
‹ 1 2 3 ... 9 ›